FDA Device Intelligence
HomeRoche Diagnostics GmbH › Elecsys Anti-HBs

Elecsys Anti-HBs

Roche Diagnostics GmbH · Model 08343594160 · UDI-DI 07613336154014

LOM Prescription
0
510(k) clearances
3,089
Adverse events (2 deaths)
33
Recalls
25
Facilities

Recalls

DateFirmReason
2025-04-24Mckesson Medical-Surgical Inc. Corporate Officetransit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failur
2025-04-24Mckesson Medical-Surgical Inc. Corporate Officetransit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failur
2024-03-01Ortho-Clinical Diagnostics, Inc.Potential for positively biased results due to signal reduction over shelf life.
2023-11-27Ortho-Clinical Diagnostics, Inc.Affected lots may experience increased calibration failures or an increase in falsely elevated results.
2022-12-22Siemens Healthcare Diagnostics, Inc.Anti-HBe2 (aHBe2) interference with the Hepatitis B e Antigen (HBeAg) Assay, leads to elevated or reactive Hepatitis B e Antigen (HBeAg) results on samples that are non-reactive wh
2018-11-01ORTHO-CLINICAL DIAGNOSTICSThe firm is extending their previous July 2018 recall to include additional product codes. Biased results may occur for these additional products at biotin concentrations which are
2018-11-01ORTHO-CLINICAL DIAGNOSTICSThe firm is extending their previous July 2018 recall to include additional product codes. Biased results may occur for these additional products at biotin concentrations which are
2018-01-02Siemens Healthcare Diagnostics, Inc.Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirol
2018-01-02Siemens Healthcare Diagnostics, Inc.Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirol
2014-09-15Siemens Healthcare Diagnostics, IncIncreased imprecision and positive bias is observed with patient samples and negative controls and can result in an increase in initial reactive results.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.